CClinicalTrials.gg
CompletedNCT05766319Updated Jun 14, 2024

The ICU-recover Box, Using Smart Technology for Monitoring Health Status After ICU Admission

An interventional study of Withings ScanWatch and Withings BPM Connect in Critically Ill, ICU Survivor and User Experience, sponsored by Leiden University Medical Center. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-14.

Sponsored by Leiden University Medical Center · Not applicable, Interventional, and Device feasibility

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

In this pilot study we will study the feasibility of providing and following ICU patients with smart technology for three months after discharge from a general ward of the Leiden University Medical Centre.

Read the detailed description

Rationale: Smart technology could improve quality of care in patients who have been admitted to the ICU and have been discharged from ICU and hospital, by early diagnosis of complications and early (ambulatory) treatment.

In times of increasing medical care consumption leading to increasing health care costs the investigators have to adopt new ways of acquiring patient-specific knowledge and new ways of delivering care. To obtain this level of insight the investigators need a smart and connected health care system. With the ICU-Recover Box and its smart technology we see new opportunities to improve patient health and to recognise early if escalation of medical care is needed. By intervening early the investigators can reduce costs by reducing health care utilization.

Objectives: The primary objective of the pilot study is to assess the feasibility of the introduction and use of smart technology by persons that have been discharged from the ICU in the three months following hospital discharge. If this pilot study proves to be successful, smart technology will be used in future studies.

Study design: This is a single center cohort study. Study population: The study population consists of 15 patients who have been discharged from the ICU Department to a general ward of the Leiden University Medical Centre.

Intervention: Patients who consent to take part in the study, receive an ICU-Recover Box closely before hospital discharge on the general ward. The ICU-Recover Box will contain a smartphone compatible blood pressure monitor, weight scale, and a watch containing a peripheral oxygen saturation monitor, a pedometer to monitor activity for home monitoring. Never will results of any of the measurements be used for therapy or diagnosis.

Main study parameters/endpoints: The primary endpoint of the study will be the feasibility of providing and following ICU patients with smart technology for three months after discharge from a general ward of the Leiden University Medical Centre.

02

Conditions studied

  • Critically Ill
  • ICU Survivor
  • User Experience

Browse trials for

Keywords

  • E-health
  • Home monitoring devices
  • Smartphone-enabled
  • Health monitoring devices
  • Smart devices
  • User experience
03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's enrollment of 15 is below the median of 90 across 979 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Leiden University Medical Center is the lead sponsor of 326 studies on the registry; 106 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

  • Patient has been admitted to the ICU of the LUMC for > 48 hours.
  • Patient has received mechanical ventilation for > 24 hours.
  • Patient masters the English or Dutch language.
  • Patient is able and capable to use smart technology at home. (i.e. Wi-Fi available, sufficient comprehension of smart technology).
  • Patient can be contacted and informed about the ICU-Recover box on one of the clinical wards of the LUMC.
  • Patient is discharged from a ward within the LUMC to home..

Exclusion criteria

Exclusion Criteria:

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Patient is \< 18 years old.
  • Patient is pregnant.
  • Patient breastfeeds during the course of the study
  • Patient underwent cardiothoracic surgery (as they will receive the Cardiothoracic Box in another study).
  • Patient is discharged for palliative care.
  • Patient is considered an incapacitated adult.
  • Patient is unwilling to sign the informed consent form.
  • Patient is discharged to another hospital.
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Patients receiving the ICU-recover box containing home monitoring devices

    Treatment of subjects on the ICU will be state of the art, conform current practice, protocols and guidelines. Patients discharged from the ICU will receive an ICU-Recover Box on one of the clinical wards of the LUMC filled with several devices after they have given informed consent. These devices are listed below and are described in further detail in section 6 of this protocol. The ICU-Recover Box contains the following devices and tools: * Withings BPM Connect * Withings Body weight scale * Withings ScanWatch, from which the following features will be used: * Measurement of SpO2 * Automatic recording of heart rate * Automatic recording of activity (step count)

    Device: Withings ScanWatch · Device: Withings BPM Connect · Device: Withings Body

Interventions

  • DeviceWithings ScanWatch

    Withings ScanWatch, from which the following features will be used: * Measurement of peripheral oxygen saturation (%) * Automatic recording of heart rate (beats/min) * Automatic recording of activity (step count) (numbers/day)

  • DeviceWithings BPM Connect

    Withings BPM connect, from which the following feature will be used: o Measurement of non invasive bloodpressure (mmHg)

  • DeviceWithings Body

    Withings Body (Scale), from which the following feature will be used: o Measurement of body weight (kg)

06

What researchers measure

Primary outcomes

  1. Feasibility of using home monitoring devices in terms of patient number

    Primary endpoint of this study is the feasibility of providing patients with the ICU-Recover Box after ICU discharge and before hospital discharge, including the collection of measurement/questionnaire data after hospital discharge. This study will be used to identify the issues when implementing such a system. Feasibility is defined as: 10 post-ICU patients, who gave informed consent and who were discharged from hospital with the ICU-Recover Box, were able to use the devices within its intended use.

    Time frame: three months

  2. Feasibility of using home monitoring devices in terms of data acquisition

    We were able to acquire data from the devices in the ICU-Recover Box. * Heart rate ( beats/min ) from the Withings ScanWartch * steps/day from the Withings ScanWatch * peripheral oxygen saturation (%) from the Withings ScanWatch * weight ( kg) from Withings Body * Blood pressure ( mmHg) from Withings BPM Connect

    Time frame: three months

  3. Feasibility of using home monitoring devices in terms of data storage

    · We were able to store the acquired data in a safe manner in the datasafe of the LUMC

    Time frame: three months

  4. Feasibility of using home monitoring devices in terms of data analyzability

    · We were able to analyse the acquired data (using Python).

    Time frame: three to six months

  5. Feasibility of using home monitoring devices

    · · \> 80 % of the persons that were discharged with an ICU-Recover Box contributed for three months to post-ICU data

    Time frame: six months

Secondary outcomes

  1. Acceptability of home monitoring

    Secondary endpoints are: · Users, i.e. post-ICU patients, have been asked, by short interviews, for feedback and suggested a

    Time frame: three months

  2. Improvements of home monitoring

    · By means of PDCA cycli, the lessons learned and feedback will have led to adjustment and improvement of the ICU-Recover Box, from its content and its use to data acquisition and data analysis.

    Time frame: three months

07

Study locations

1 site
  • Leiden University Medical Center
    Leiden, Zuid-Holland 2333 ZA, Netherlands
08

References and documents

Individual participant data

Plan to share: Yes — Data obtained through this study may be provided to qualified researchers with academic interest in home monitoring of ICU survivors. Data will be coded, with no PHI included. Approval of the request and execution of all applicable agreements (i.e. a data transfer agreement) are prerequisites to the sharing of data with the requesting party.

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05766319
Lead sponsor
Leiden University Medical Center
Responsible party
Sesmu M. Arbous, MD PhD MSc (dr., Leiden University Medical Center) — Principal investigator
First posted
Mar 13, 2023
Start date
Sep 26, 2022
Primary completion
May 31, 2024
Completion
May 31, 2024
Last update
Jun 14, 2024

Study contacts

Sesmu Arbous, MD PhD
principal investigator · LUMC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion